Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Urology-Nephrology
»
Neoplasia/BPH
22. November 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Anzeige
Zoom:
Page 1 of 9655
Articles 1 - 20 / 193081
Adaptive radiotherapy for bladder cancer.
Cancer Radiother
Cravéreau O, Demogeot N, Martz N, Michalet M, Riou O.
PMID: 43067064 [PubMed - as supplied by publisher]
Orthotopic Neobladder after Radical Cystectomy: Contemporary Patient Selection, Outcomes and Survivorship.
Curr Treat Options Oncol
Imperatore V, Coppola P, Sciorio C, Di Girolamo A, Romeo G, Giannella R, Romano L, Ruffo A, Napolitano L, Stanzione F, Esposito F, Spirito L.
PMID: 43066856 [PubMed - indexed for MEDLINE]
Can we trust a positive PSMA PET/CT before the Phoenix threshold? Positive predictive value after primary radiotherapy for prostate cancer. A retrospective cohort study.
Eur J Nucl Med Mol Imaging
van Altena EJE, Oprea-Lager DE, Scheltema MJV, Lam MGEH, van der Voort van Zyp JRN, van Leeuwen PJ, Vis AN, Jansen BHE.
PMID: 43066798 [PubMed - indexed for MEDLINE]
Diagnostic Performance of Serum Biglycan for Prostate Cancer Detection in Men With PSA Levels of 4-10 ng/mL.
Urol Int
Yavuz E, Coban S, Akpinar O, Keskin ET, Colakoglu Y, Akalin B, Simsek A.
PMID: 43066658 [PubMed - as supplied by publisher]
Pre-Diagnostic Circulating Glycerolipids Are Enriched in Men Who Develop Advanced Prostate Cancer: A Nested Case-Control Study.
Int J Cancer
Graff RE, Fuller H, Wilson KM, Dickerman BA, Chan JM, Kantoff PW, Feng X, Clish CB, Vander Heiden MG, Darst BF, Ebot EM, Mucci LA.
PMID: 43066525 [PubMed - as supplied by publisher]
Computational and Experimental Studies of PSMA-Targeted Conjugates Designed for Subcellular Delivery of Theranostic Radiometals to Prostate Cancer Cells.
ACS Omega
Sobral MC, Urbano AM, Mota SI, Oliveira PJ, Rosa CF, Santos JF, Fernandes C, Melo R, Paulo A.
PMID: 43066275 [PubMed]
Gut microbiome-derived metabolites in prostate cancer: microbial mechanisms of immune modulation, androgen metabolism, and therapeutic implications.
Front Microbiol
Mi J, Wang P, Wu F, Xiao X.
PMID: 43065960 [PubMed]
Evidence-Graded Extracellular Vesicle Cargo Coordination in Renal Cell Carcinoma: Mechanisms and Translational Implications.
Int J Nanomedicine
Jiang C, Zhao J, Chen G, Lou K, Liu H.
PMID: 43065950 [PubMed - indexed for MEDLINE]
Laparoscopic versus robot-assisted radical prostatectomy: trifecta outcomes in prostate cancer surgery.
Front Urol
Nadeem F, Motiwala ZY, Misra S, Shamsi L, Khandagale S, Carbin DD.
PMID: 43065747 [PubMed]
Outcomes of robot-assisted cystectomy and intracorporeal ileal conduit diversion in radiotherapy-exposed patients: propensity-score matched analysis.
World J Urol
Ibrahim Y, Rajain S, Abu-Ghanem Y, Ribeiro L, Bhatti N, Yuan J, Chandrasekhar K, Giudice FD, Santarelli V, Gad M, O'Kelly J, Warren H, Kam J, Khan MS, Nair R, Thurairaja R.
PMID: 43064862 [PubMed - indexed for MEDLINE]
Multimodal lifestyle strategies for ADT-induced osteosarcopenia and metabolic dysfunction in prostate cancer.
Support Care Cancer
Ambrosio F, Persia M, Bellieni A, Tagliaferri L, Gambacorta MA, Frascino V, Abbatecola G, Landi F, Colloca GF.
PMID: 43064850 [PubMed - indexed for MEDLINE]
Beyond transfusions: bleeding-related outcomes after repeat TURP.
World J Urol
Derigs M, Liu E, Lange D, Bhojani N, Wymer K, Forbes CM.
PMID: 43064844 [PubMed - indexed for MEDLINE]
Small size, major effect: microRNAs shaping testicular germ cell tumour biology and clinical practice.
Nat Rev Urol
Tavares NT, Oliveira-Lopes B, Weiss RS, Bagrodia A, Hamilton RJ, Heidenreich A, Henrique R, Jerónimo C, Lobo J.
PMID: 43064732 [PubMed - as supplied by publisher]
Artificial Intelligence in Screening and Early Detection of Prostate Cancer.
Eur Urol Focus
Cacciamani GE, Pannu AS, Thimansson E, Bjartell A.
PMID: 43064602 [PubMed - as supplied by publisher]
Re: Stereotactic Body Radiotherapy Versus Moderately Hypofractionated IMRT for Localized Intermediate-risk Prostate Cancer: A Randomized Clinical Trial.
Eur Urol
Kishan AU, Samala SK, Nagar H.
PMID: 43064549 [PubMed - as supplied by publisher]
Re: Anke Richters, Marinde J. G. Bond, Hans M. Westgeest, et al. Development and External Validation of a New Prognostic Model for Metastatic Clear Cell Renal Cell Carcinoma: A Preregistered Analysis Using Data from Randomised Clinical Trials in the Checkpoint Inhibitor Era. Lancet Oncol 2026;27:1295-303.
Eur Urol
Massari F, Rosellini M, Santoni M, Mollica V.
PMID: 43064548 [PubMed - as supplied by publisher]
Prostate and pelvic nodal stereotactic body radiotherapy (SBRT) versus prostate-only SBRT for high-risk, localised prostate cancer (PACE-NODES): early adverse event results from an international, open-label, phase 3, randomised controlled trial.
Lancet Oncol
Pathmanathan A, Jain S, Cafferty FH, Leaning D, Chan A, Venkitaraman R, Varughese M, Panades M, Ward T, Tree A, Syndikus I, Staffurth J, Song YP, Das P, McGrane J, Pugh J, Naismith O, Murthy V, McGarry CK, McBride K, Kelly P, Hoskin P, Hallett J, Dewan M, Clees-Baron H, Choudhury A, Burnett S, Brown S, Hall E, van As N.
PMID: 43063962 [PubMed - as supplied by publisher]
Metformin use and all-cause and cause-specific mortality in patients with kidney cancer: a nationwide Korean cohort study.
Cancer Treat Res Commun
Sim Y, Jung G, Shim M, Kim JH, Kim MJ, Kim Y, Kim YJ, Kim KN, Jo JK.
PMID: 43063679 [PubMed - as supplied by publisher]
Overall Survival With [(177)Lu]Lu-PSMA-617 in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Bayesian Reanalysis of the PSMAfore Trial.
JCO Clin Cancer Inform
Satapathy S, Chandekar KR.
PMID: 43063372 [PubMed - indexed for MEDLINE]
Evaluation of the efficacy and safety of particle therapy for kidney cancer through a multicenter registry study and meta-analysis.
J Radiat Res
Nishioka K, Ishikawa H, Maruo K, Kawamura H, Iizumi T, Sato H, Toyama S, Mori T, Suzuki O, Okimoto T, Ogino T, Murakami M, Tamamura H, Shibamoto Y, Umehara K, Hashimoto T, Aoyama H, Sakurai H.
PMID: 43062948 [PubMed - as supplied by publisher]
Articles 1 - 20 / 193081
Page 1 of 9655
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy